Author

V. M. Wang

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Animal Behavior & Cognition· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:behavioral assay· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1

Frequent Co-Authors

J. A. Roth· 2 shared L. Wang· 2 shared N. J. Lyons· 2 shared T. R. Golub· 2 shared A. A. Tang· 1 shared A. Brown· 1 shared A. Goodale· 1 shared A. Karger· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. A. Roth

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Control of wildtype zebrafish optomotor response with a photoswitchable drug

Luisa Camerin, Joaquín Martínez‐Tambella, Gregor F. P. Schuhknecht, V. M. Wang, K. Krishnan, Paula Pflitsch, Florian Engert, Pau Gorostiza

This study uses Carbadiazocine to modulate optomotor responses in zebrafish larvae, showing reduced accuracy and altered movement patterns when activated by light.

bioRxiv · Mar 7, 2026 · PreprintAnimal Behavior & Cognition

Non-canonical open reading frames encode functional proteins essential for cancer cell survival

J. R. Prensner, O. M. Enache, V. Luria, K. Krug, K. R. Clauser, J. M. Dempster, A. Karger, L. Wang, K. Stumbraite, V. M. Wang, G. Botta, N. J. Lyons, A. Goodale, Z. Kalani, B. Fritchman, , T. R. Golub

The paper identifies non-canonical open reading frames (ORFs) that encode functional proteins essential for cancer cell survival, with one example, GREP1, showing preferential essentiality in breast cancer.

bioRxiv · Mar 10, 2020 · PreprintCancer Biology

Non-oncology drugs are a source of previously unappreciated anti-cancer activity

S. M. Corsello, R. T. Nagari, R. D. Spangler, J. Rossen, M. Kocak, J. G. Bryan, R. Humeidi, D. Peck, X. Wu, A. A. Tang, V. M. Wang, S. A. Bender, E. Lemire, R. Narayan, P. Montgomery, , T. R. Golub

The paper identifies non-oncology drugs with anti-cancer activity across 578 cancer cell lines using PRISM, finding that many drugs selectively inhibit cancer cells based on molecular features.

bioRxiv · Aug 9, 2019Cancer Biology